Evoke Pharma Inc Quarterly Return On Assets in % from Q2 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Evoke Pharma Inc quarterly/annual Return On Assets history and growth rate from Q2 2014 to Q3 2024.
  • Evoke Pharma Inc Return On Assets for the quarter ending September 30, 2024 was -53.7 %, a 31.7% increase year-over-year.
  • Evoke Pharma Inc annual Return On Assets for 2023 was -91.8 %, a 35.9% decline from 2022.
  • Evoke Pharma Inc annual Return On Assets for 2022 was -67.6 %, a 16.9% decline from 2021.
  • Evoke Pharma Inc annual Return On Assets for 2021 was -57.8 %, a 68% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -53.7 +24.9 +31.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -66.1 +5.53 +7.72% Apr 1, 2024 Jun 30, 2024
Q1 2024 -78.4 -11.7 -17.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -91.8 -24.3 -35.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -78.6 -10.3 -15.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -71.6 -1.1 -1.56% Apr 1, 2023 Jun 30, 2023
Q1 2023 -66.7 -0.31 -0.47% Jan 1, 2023 Mar 31, 2023
Q4 2022 -67.6 -9.75 -16.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -68.3 -5.22 -8.28% Jul 1, 2022 Sep 30, 2022
Q2 2022 -70.5 -0.43 -0.61% Apr 1, 2022 Jun 30, 2022
Q1 2022 -66.4 +61.3 +48% Jan 1, 2022 Mar 31, 2022
Q4 2021 -57.8 +123 +68% Oct 1, 2021 Dec 31, 2021
Q3 2021 -63.1 +126 +66.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -70.1 +107 +60.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -128 -20.8 -19.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -181 -70.1 -63.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -189 -69.4 -58% Jul 1, 2020 Sep 30, 2020
Q2 2020 -177 -58 -48.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -107 +20.6 +16.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -111 +10.8 +8.85% Oct 1, 2019 Dec 31, 2019
Q3 2019 -120 -29.6 -32.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -119 +7.98 +6.27% Apr 1, 2019 Jun 30, 2019
Q1 2019 -128 -29.7 -30.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -122 -16.8 -16.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -90 +22 +19.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -127 -33.9 -36.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -97.9 +29.2 +23% Jan 1, 2018 Mar 31, 2018
Q4 2017 -105 +31.2 +23% Oct 1, 2017 Dec 31, 2017
Q3 2017 -112 +36.8 +24.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -93.4 +47.9 +33.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 -127 -4.83 -3.95% Jan 1, 2017 Mar 31, 2017
Q4 2016 -136 -26.9 -24.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 -149 -49.7 -50.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -141 -37.1 -35.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -122 -27.4 -28.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -109 -31.4 -40.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -99.1 -37.8 -61.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -104 -65.2 -167% Apr 1, 2015 Jun 30, 2015
Q1 2015 -94.8 Jan 1, 2015 Mar 31, 2015
Q4 2014 -77.7 Oct 1, 2014 Dec 31, 2014
Q3 2014 -61.3 Jul 1, 2014 Sep 30, 2014
Q2 2014 -39 Apr 1, 2014 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.